Jiwen Cheng

1.1k citations
36 papers · 668 indexed · h-index 12
Topics
Single-cell and spatial transcriptomics (8 papers)Renal cell carcinoma treatment (7 papers)Bladder and Urothelial Cancer Treatments (7 papers)
Partner nations
ChinaItalyFinland

In The Last Decade

Jiwen Cheng

34 papers receiving 662 citations

Peers

Jiwen Cheng
Comparison fields: 5 of 89
  • Molecular Biology 360
  • Pulmonary and Respiratory Medicine 181
  • Cancer Research 161
  • Oncology 152
  • Surgery 109
Replace Fei Lian with:
Fei Lian United States
Tzu-Ting Hsu Australia
Yijie Han China
Libin Yan China
Riana K. Parvez United States
Rachel Palmer United States
Ilaria Deambrosis Italy
Robert Rzepko Poland
Giorgia Mandrile Italy
Amy M. Becker United States
Jiwen Cheng relative to Fei Lian United States Fei Lian's profile →
Citations per field
00.5×3.4×
Fei Lian · 1×
Citations per year

Countries citing papers authored by Jiwen Cheng

Since Specialization
Citations

This map shows the geographic impact of Jiwen Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiwen Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiwen Cheng more than expected).

Fields of papers citing papers by Jiwen Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiwen Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiwen Cheng. The network helps show where Jiwen Cheng may publish in the future.

Co-authorship network of co-authors of Jiwen Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Jiwen Cheng. A scholar is included among the top collaborators of Jiwen Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiwen Cheng. Jiwen Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 1
3 3
4 0
5 45
6 7
7 4
8 1
9 15
10 4
11 3
12 71
13
Standardized training in robotic surgery in urology and andrology
1
14 12
15 15
16 166
17 16
18 0
19 3
20 4

About Jiwen Cheng

Jiwen Cheng is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 36 papers that have together received 668 indexed citations. Recurring topics across this work include Single-cell and spatial transcriptomics (8 papers), Renal cell carcinoma treatment (7 papers) and Bladder and Urothelial Cancer Treatments (7 papers). The work is most often cited by research in Cancer Research (161 citations), Nephrology (46 citations) and Oncology (152 citations). Jiwen Cheng has collaborated with scholars based in China, Italy and Finland. Frequent co-authors include Zengnan Mo, Zhenyuan Yu, Deyun Liu, Qingyun Zhang, Tianyu Li, Jinling Liao, Haiying Zhang, Chunlin Zou, Jiaping Li and Mengying Bao. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026